Cargando…
Long noncoding RNA RP11-838N2.4 enhances the cytotoxic effects of temozolomide by inhibiting the functions of miR-10a in glioblastoma cell lines
Resistance to temolozomide (TMZ), the standard chemotherapy agent for treating glioblastomas (GBM), is a major clinical problem for patients with GBM. Recently, long noncoding RNAs (lncRNAs) have been implicated in chemotherapy resistance in various cancers. In this study, we found that the level of...
Autores principales: | Liu, Yanting, Xu, Ningbo, Liu, Boyang, Huang, Yiru, Zeng, Huijun, Yang, Zhao, He, Zhenyan, Guo, Hongbo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5190063/ https://www.ncbi.nlm.nih.gov/pubmed/27270310 http://dx.doi.org/10.18632/oncotarget.9699 |
Ejemplares similares
-
Long noncoding RNA AC003092.1 promotes temozolomide chemosensitivity through miR-195/TFPI-2 signaling modulation in glioblastoma
por: Xu, Ningbo, et al.
Publicado: (2018) -
Genomic profiling of long non-coding RNA and mRNA expression associated with acquired temozolomide resistance in glioblastoma cells
por: Zeng, Huijun, et al.
Publicado: (2017) -
Connective tissue growth factor promotes temozolomide resistance in glioblastoma through TGF-β1-dependent activation of Smad/ERK signaling
por: Zeng, Huijun, et al.
Publicado: (2017) -
lncRNA RP11-838N2.3 Promoted Cisplatin Resistance in Lung Adenocarcinoma
por: Chen, Jie, et al.
Publicado: (2020) -
Exosome-mediated transfer of lncRNA RP11-838N2.4 promotes erlotinib resistance in non-small cell lung cancer
por: Zhang, Wei, et al.
Publicado: (2018)